Search results for "Coronavirus"
New COVID-19 vaccines tested, authorization changes in progress for existing vaccines
The FDA further limited use of the Johnson & Johnson (Janssen) vaccine and scheduled advisory committee meetings on other vaccine questions. Two non-mRNA vaccines showed effectiveness, and other studies looked at antibody prevalence, home test accuracy, and long-term symptoms.
https://immattersacp.org/weekly/archives/2022/05/10/2.htm
10 May 2022
Optimism on outpatient COVID-19 treatment options
ACP and Annals of Internal Medicine's seventh forum on COVID-19 tackled new and existing treatments amid a rising number of cases from the omicron variant.
https://immattersacp.org/archives/2022/01/optimism-on-outpatient-covid-19-treatment-options.htm
1 Jan 2022
ACP, Annals of Internal Medicine host ninth forum on COVID-19
A full recording of COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19 is available for replay online.
https://immattersacp.org/weekly/archives/2022/05/31/4.htm
31 May 2022
A new vision for health care
ACP's vision for health care entails a series of policy papers and editorials outlining improvements to the U.S. health care system.
https://immattersacp.org/archives/2020/07/a-new-vision-for-health-care.htm
1 Jul 2020
Register now for next ACP, Annals of Internal Medicine forum on COVID-19
On Oct. 8, panelists will provide insight on the clinical implications of the immunology of SARS-CoV-2 and the COVID-19 vaccine, including the status of booster doses and the efficacy of vaccination in various groups.
https://immattersacp.org/weekly/archives/2021/10/05/2.htm
5 Oct 2021
Celebrate mental health awareness every day
Recognizing mental health entails the individual acknowledging it and seeking help, society not stigmatizing those suffering from mental and behavioral disorders, and the nation providing adequate resources and personnel to address the problem.
https://immattersacp.org/archives/2022/05/celebrate-mental-health-awareness-every-day.htm
1 May 2022
Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://immattersacp.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022
Residents reimagine antiracism curriculum
Residents interested in diversity, equity, and inclusion are taking matters into their own hands, creating new training initiatives about the subject as a formal part of their medical school curriculum.
https://immattersacp.org/archives/2021/07/residents-reimagine-antiracism-curriculum.htm
1 Jul 2021
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VIII: Outpatient Evaluation and Management of Patients with COVID-19
During the Feb. 9 virtual live event, a panel of experts will discuss appropriate COVID-19 testing, quarantine and isolation periods, management of symptoms, and recommended treatments in the outpatient setting.
https://immattersacp.org/weekly/archives/2022/02/01/2.htm
1 Feb 2022
Monoclonal antibodies appear safe as COVID-19 treatment during pregnancy
Pregnant patients who received monoclonal antibody treatments had no higher risk for adverse obstetric events but also no significant improvement on COVID-19-related outcomes, a retrospective study found.
https://immattersacp.org/weekly/archives/2022/11/15/2.htm
15 Nov 2022